7th April 2017, Volume 130 Number 1453

John Fink

Stroke is a major health burden to New Zealanders. Approximately 6,000 New Zealanders suffer from a stroke every year.1 Stroke is the third largest cause of death behind heart disease…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Author Information

John Fink, Department of Neurology, Canterbury District Health Board and University of Otago, Christchurch.

Correspondence

Dr John Fink, Department of Neurology, Canterbury District Health Board and University of Otago, Riccarton Avenue, Christchurch.

Correspondence Email

john.fink@cdhb.health.nz

Competing Interests

Nil.

References

  1. Stroke Foundation of New Zealand. New Zealand Clinical Guidelines for Stroke Management, 2010. 
  2. Mortality 2014 data tables, Ministry of Health. http://www.health.govt.nz/publication/mortality-2014-data-tables 
  3. Wolfe CDA. The impact of Stroke. British Medical Bulletin 2000; 56:275–286.
  4. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384:1929–35.
  5. Liu Q, Barber PA, Abernethy G, Ranta A. Provision of stroke thrombolysis services in New Zealand: changes between 2011 and 2016. NZ Med J 2017; 130(1453):57–62.
  6. Liu Q, Ranta A, Abernethy G, Barber PA. Trends in New Zealand stroke thrombolysis treatment rates. NZ Med J 2017; 130(1453):50–56.

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe